Correction: Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117)

Page Axley; Sandhya Mudumbi; Shabnam Sarker; Yong Fang Kuo; Ashwani K. Singal

doi:10.1371/journal.pone.0199402

Correction: Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117)

Page Axley, Sandhya Mudumbi, Shabnam Sarker, Yong Fang Kuo, Ashwani K. Singal

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

The fifth author’s middle initial is missing. The correct name is: Ashwani K. Singal. The correct citation is: Axley P, Mudumbi S, Sarker S, Kuo Y-F, Singal AK (2018) Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE 13(5): e0197117. https://doi.org/10.1371/journal.pone.0197117.

Original language	English (US)
Article number	e0199402
Journal	PLoS One
Volume	13
Issue number	8
DOIs	https://doi.org/10.1371/journal.pone.0199402
State	Published - Aug 1 2018
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)

Cite this

Axley, P., Mudumbi, S., Sarker, S., Kuo, Y. F., & Singal, A. K. (2018). Correction: Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117). PLoS One, 13(8), [e0199402]. https://doi.org/10.1371/journal.pone.0199402

Correction : Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117). / Axley, Page; Mudumbi, Sandhya; Sarker, Shabnam; Kuo, Yong Fang; Singal, Ashwani K.

In: PLoS One, Vol. 13, No. 8, e0199402, 01.08.2018.

Research output: Contribution to journal › Comment/debate

@article{f69141b11b6f4e1e910ec548ebd9746b,

title = "Correction: Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117)",

abstract = "The fifth author{\textquoteright}s middle initial is missing. The correct name is: Ashwani K. Singal. The correct citation is: Axley P, Mudumbi S, Sarker S, Kuo Y-F, Singal AK (2018) Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE 13(5): e0197117. https://doi.org/10.1371/journal.pone.0197117.",

author = "Page Axley and Sandhya Mudumbi and Shabnam Sarker and Kuo, {Yong Fang} and Singal, {Ashwani K.}",

year = "2018",

month = aug

day = "1",

doi = "10.1371/journal.pone.0199402",

language = "English (US)",

volume = "13",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "8",

}

TY - JOUR

T1 - Correction

T2 - Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117)

AU - Axley, Page

AU - Mudumbi, Sandhya

AU - Sarker, Shabnam

AU - Kuo, Yong Fang

AU - Singal, Ashwani K.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - The fifth author’s middle initial is missing. The correct name is: Ashwani K. Singal. The correct citation is: Axley P, Mudumbi S, Sarker S, Kuo Y-F, Singal AK (2018) Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE 13(5): e0197117. https://doi.org/10.1371/journal.pone.0197117.

AB - The fifth author’s middle initial is missing. The correct name is: Ashwani K. Singal. The correct citation is: Axley P, Mudumbi S, Sarker S, Kuo Y-F, Singal AK (2018) Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE 13(5): e0197117. https://doi.org/10.1371/journal.pone.0197117.

UR - http://www.scopus.com/inward/record.url?scp=85051215442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051215442&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0199402

DO - 10.1371/journal.pone.0199402

M3 - Comment/debate

C2 - 30071024

AN - SCOPUS:85051215442

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e0199402

ER -

Access to Document

10.1371/journal.pone.0199402